(Q43517056)

24 November 2017

Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients (English)

1 reference

24 November 2017

1 reference

1 reference

1 reference

7

1 reference

24 November 2017

Trine Lembrecht Jørgensen

1

1 reference

24 November 2017

Sandra Teiblum

2

1 reference

24 November 2017

Merete Paludan

3

1 reference

24 November 2017

Laurids Østergaard Poulsen

4

1 reference

24 November 2017

Anni Young Stensgård Jørgensen

5

1 reference

24 November 2017

Karin Herskind Bruun

6

1 reference

24 November 2017

Jørn Herrstedt

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

16 July 2012

1 reference

24 November 2017

1 reference

24 November 2017

127

1 reference

24 November 2017

2

1 reference

24 November 2017

367-374

1 reference

24 November 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Ovarian cancer in younger vs older women: a population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

The Danish Cancer Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

The Danish Register of Causes of Death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

GRADING OF PATIENTS FOR SURGICAL PROCEDURES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

ASA physical status classifications: a study of consistency of ratings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Comprehensive geriatric assessment for older patients with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Older female cancer patients: importance, causes, and consequences of undertreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Survival and prognostic factors in patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.07.001

10.1016/J.YGYNO.2012.07.001

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference